Relative to its peers, MESO does not have very much institutional sponsorship. The 2.68% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DEUTSCHE ASSET MANAGEMENT INVEST... Bought 23.0 Thousand shares of Mesoblast Ltd
RENAISSANCE TECHNOLOGIES LLC Bought 22.7 Thousand shares of Mesoblast Ltd
DILIGENT INVESTORS LLC Bought 12.3 Thousand shares of Mesoblast Ltd